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CpG-induced tyrosine phosphorylation occurs via
a TLR9-independent mechanism and is required
for cytokine secretion
Miguel A. Sanjuan,1 Navin Rao,1 Kuei-Tai A. Lai,1 Yin Gu,1 Siquan Sun,1 Anja Fuchs,2 Wai-Ping Fung-Leung,1
Marco Colonna,2 and Lars Karlsson1
1

Johnson & Johnson Pharmaceutical Research and Development, L.L.C., San Diego, CA 92121
Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO 63110

T

oll-like receptors (TLRs) recognize molecular patterns
preferentially expressed by pathogens. In endosomes, TLR9 is activated by unmethylated bacterial
DNA, resulting in proinﬂammatory cytokine secretion via
the adaptor protein MyD88. We demonstrate that CpG
oligonucleotides activate a TLR9-independent pathway
initiated by two Src family kinases, Hck and Lyn, which
trigger a tyrosine phosphorylation–mediated signaling
cascade. This cascade induces actin cytoskeleton reorganization, resulting in cell spreading, adhesion, and motility.
CpG-induced actin polymerization originates at the plasma
membrane, rather than in endosomes. Chloroquine, an

inhibitor of CpG-triggered cytokine secretion, blocked
TLR9/MyD88-dependent cytokine secretion as expected
but failed to inhibit CpG-induced Src family kinase activation and its dependent cellular responses. Knock down of Src
family kinase expression or the use of speciﬁc kinase inhibitors blocked MyD88-dependent signaling and cytokine
secretion, providing evidence that tyrosine phosphorylation is both CpG induced and an upstream requirement
for the engagement of TLR9. The Src family pathway intersects the TLR9–MyD88 pathway by promoting the tyrosine
phosphorylation of TLR9 and the recruitment of Syk to
this receptor.

Introduction
Upon recognizing pathogen-associated molecular patterns, the
family of 11 Toll-like receptors (TLRs) provides the initial activation signal to the immune system, resulting in costimulatory
molecule expression and cytokine secretion (Krieg, 2002a;
Takeda et al., 2003). These cytokines can modulate the adaptive
immune response to eliminate particular classes of pathogens
by polarizing CD4+ T cells to either a Th1 or -2 phenotype
(Krieg, 2002b). However, an unbalanced or sustained Th1 or -2
response can lead to diseases such as rheumatoid arthritis and
asthma (Trinchieri, 2003).
The pathogen-associated molecular pattern of unmethylated bacterial DNA is specifically recognized by TLR9, and its
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immunomodulatory effects can be mimicked by oligodeoxynucleotides (ODNs) containing unmethylated deoxycytidyldeoxyguanosine (CpG) motifs (CpG-ODN; Krieg, 2002b).
TLR9, expressed by B cells, macrophages, and dendritic cells
(DCs), recognizes CpG in the acidic environment of the
endosome (Ahmad-Nejad et al., 2002). Variant sequences flanking the stimulatory CpG core motif have been described for
optimal TLR9 activation expressed by specific cell types.
Depending on the cytokines secreted, those ODNs have been
categorized as A, B, or C class ODNs; however, it remains
unclear why specific CpG sequences trigger different biological
effects (Krieg, 2002b).
Studies using fluorescently labeled ODNs indicate that both
stimulatory and nonstimulatory ODNs are internalized nonspecifically, but only stimulatory ODNs activate TLR9 in endosomes,
where both ligand and receptor colocalize (Hacker et al., 1998;
Latz et al., 2004; Leifer et al., 2004; Takeda and Akira, 2005).
Uptake of ODN is dependent on dose, time, and temperature but
independent of the CpG motif (Guo and Schluesener, 2004).
Upon recognition of CpG-rich sequences in the endosome, TLR9 initiates a conserved TLR family signaling cascade
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that begins with the recruitment of the adaptor protein MyD88
via the Toll/interleukin (IL) 1 receptor domain (Ahmad-Nejad
et al., 2002). MyD88 then recruits IL-1 receptor–associated
kinase (IRAK) 1 and 4 (Wesche et al., 1997). When phosphorylated by IRAK-4, IRAK-1 interacts with TRAF6 (TNF receptor–
associated factor 6; Cao et al., 1996; Li et al., 2002) and
disengages from the receptor. A complex consisting of TRAF6,
TAK1 (TGFβ-activated kinase 1), and TAB (TAK1 binding
protein) 1 and 2 goes on to activate the IκB kinase complex,
resulting in nuclear factor (NF) κB translocation to the nucleus
(Mercurio et al., 1997; Regnier et al., 1997; Jiang et al., 2003).
CpG-induced NF-κB activation initiates the up-regulation of
costimulatory molecules and the secretion of proinflammatory
cytokines, such as TNFα and IL-6.
The adaptor protein MyD88 plays a crucial role in transducing signals from TLR family members. Upon binding to
TLR4, bacterial lipopolysaccharide not only activates NF-κB via

the MyD88–IRAK serine/threonine kinase pathway but also
induces tyrosine phosphorylation in macrophages (Weinstein
et al., 1991). Two Src family kinases (SFKs), Hck and
Lyn, are responsible for initiating this pathway (English et al.,
1993; Beaty et al., 1994). Hck has been shown to regulate
differentiation and several actin-dependent processes such as
F-actin–based membrane protrusions (Carreno et al., 2002),
monocyte chemotaxis (Resnati et al., 1996; Chiaradonna et al.,
1999), phagocytosis (Suzuki et al., 2000; Le Cabec et al.,
2002), and cellular adhesion (Suen et al., 1999; Scholz et al.,
2000). In the well-characterized system of Fcγ receptor signaling, Hck and Lyn are the initiating tyrosine kinases that phosphorylate immunoreceptor tyrosine-based activation motifs
(ITAMs) in the signaling chains of the receptor complex, which
then serve as docking sites for a second tier of tyrosine kinases
such as Syk (Bolen and Brugge, 1997). Both Src and Syk
family kinases phosphorylate several downstream signaling
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Figure 1. SFKs initiate a chloroquineinsensitive, CpG-triggered tyrosine phosphorylation cascade. (A) THP-1 monocytes were
stimulated with a control ODN, GpC (lanes
1–3), and CpG–ODN 2216 (lanes 4–6) at
1 μg/ml for the indicated times. 50-μg aliquots of lysate were subjected to SDS-PAGE
followed by immunoblotting with an anti-pTyr
antibody. Loading controls were immunoblotted
with an anti-actin antibody. (B) Individual phosphoproteins were immunoprecipitated with
the indicated antibodies from 100 μg of GpCor CpG-stimulated (3 min) cell lysate and
then immunoblotted with anti-pTyr antibody.
(C) THP-1 cells were pretreated for 30 min with
vehicle (lanes 1–3), 10 μM chloroquine (lanes
4–6), 1 μM quinacrine (lanes 7–9), 1 μM of
the SFK inhibitor PP2 (lanes 10–13), and
1 μM of the control inhibitor PP3 (lanes 13–15).
Lysates were prepared after CpG stimulation
and immunoblotted with anti-pTyr antibody.
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Results
CpG induces SFK activation

The role of SFKs after CpG-ODN treatment is unclear. To study
the role of tyrosine kinases in TLR9 signaling, we stimulated the
human monocyte cell line THP-1 with a control GpC and an activating CpG-ODN. Cell lysates were then analyzed by immunoblotting with an anti-phosphotyrosine (pTyr) antibody. CpG
treatment induced rapid tyrosine phosphorylation of multiple
proteins, with maximum phosphorylation achieved 3 min after
stimulation (Fig. 1 A, lanes 4–6). The control non–CpG-ODN
did not trigger tyrosine kinase activation (Fig. 1 A, lanes 1–3).
To specifically identify phosphoproteins, candidate proteins were immunoprecipitated and then immunoblotted with
anti-pTyr antibody. Major phosphoproteins of 47, 52, 70, 95,
120, and 125 kD were identified in this manner (Fig. 1 B). The
three most prominent phosphoproteins identified were the cytoplasmic tyrosine kinase Syk (70 kD), the hematopoietic-specific
exchange factor Vav1 (95 kD), and the adaptor protein Cbl
(120 kD). Two SFK members expressed in monocytic cells, Lyn
(49 kD) and Hck (52 kD), were also phosphorylated upon CpG
treatment. In addition, the hematopoietic-specific focal adhesion kinase Pyk2 (125 kD), talin (200 kD), paxillin (68 kD), and
vinculin (117 kD) were also phosphorylated. However, other
prominent B cell and macrophage tyrosine substrates, such as
B cell linker protein and Bruton’s tyrosine kinase, were not
phosphorylated upon CpG stimulation (unpublished data).
[ID]FG1/

CpG-induced tyrosine
phosphorylation is Src-kinase
dependent but chloroquine insensitive

Because our results indicated that two SFKs, Hck and Lyn, were
phosphorylated upon CpG treatment, we wanted to test whether
an SFK inhibitor could block tyrosine phosphorylation. Pretreatment of THP-1 cells with PP2, a potent SFK inhibitor,
completely blocked CpG-induced phosphorylation (Fig. 1 C,
lanes 10–12). Pretreatment with PP3, an inactive version of
PP2, had no effect on CpG-induced tyrosine phosphorylation
(Fig. 1 C, lanes 13–15). Pretreatment with two well-described
inhibitors of TLR9-induced cytokine production, chloroquine
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proteins and thus initiate multiple signaling events. It has
recently been reported that CpG-ODN stimulation induces
tyrosine phosphorylation of the GTP exchange factor Vav1
(Stovall et al., 2004).
The TLR9 inhibitor chloroquine and analogues such as
quinacrine inhibit immune stimulation by bacterial DNA and
CpG-ODN (Macfarlane and Manzel, 1998; Strekowski et al.,
1999). The inhibition of TLR9 occurs at endosomes where
chloroquine was shown to block CpG and TLR9 interaction
(Rutz et al., 2004). Chloroquine (Trape et al., 2002) has also
proven effective in the treatment of inflammatory diseases such
as systemic lupus erythematosus and rheumatoid arthritis (Fox
et al., 1987; Wallace, 2001; Araiza-Casillas et al., 2004; Nord
et al., 2004).
We have investigated the role of SFKs upon CpG-induced
TLR9 stimulation. Two SFKs, Hck and Lyn, are phosphorylated
upon monocyte stimulation with CpG-ODN but not when cells
are treated with nonstimulatory deoxyguanosine-deoxycytidyl
(GpC) ODN. The SFK-initiated tyrosine phosphorylation cascade activates signaling proteins implicated in reorganization of
the actin cytoskeleton, resulting in cell spreading, adhesion, and
motility. Surprisingly, the TLR9 inhibitor chloroquine failed
to block SFK activation and any of the signaling pathways
downstream of tyrosine kinase activation. Macrophages from
TLR9−/− and MyD88−/− mice exhibited normal SFK activation, indicating that the SFK pathway is TLR9 independent.
Unexpectedly, this pathway is triggered upstream of the
traditional TLR9 pathway, as indicated by SFK inhibitors,
which blocked CpG-induced phosphorylation of the NF-κB
regulator IκB, IL-6 secretion, and up-regulation of CD40 and
CD69. Both pathways intersect at the level of TLR9, which
is tyrosine phosphorylated upon CpG stimulation and interacts with the tyrosine kinase Syk. Furthermore, CpG-coated
beads induce strong actin polymerization at the plasma
membrane–bead contact area of macrophages in a chloroquine-insensitive manner. Together, these findings indicate
that the SFK-driven tyrosine phosphorylation pathway is an
early CpG-induced event that is initiated at the cell surface
and is upstream of and required for TLR9/MyD88 activation
in endosomes.

Figure 2. Chloroquine fails to block CpGinduced actin polymerization. Mouse
macrophages (RAW) or human monocytes
(THP-1) were pretreated for 15 min with
10 μM chloroquine (CQ) or vehicle control
and then stimulated for 20 min with 1 μg/ml
of the mouse-selective CpG–ODN 1668 or
human CpG–ODN 2216, respectively.
After ﬁxation, cells were stained with FITCphalloidin (green) and nuclei were visualized with TOPRO-3 (blue).
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and quinacrine, also had no effect on CpG-induced tyrosine
phosphorylation (Fig. 1 C, lanes 4–9).
CpG-induced actin cytoskeleton
reorganization is chloroquine insensitive

SFK activation results in cytoskeleton changes and the transcription of effector genes (Latour and Veillette, 2001). Six of
the proteins that we found to be phosphorylated upon CpG
stimulation, Pyk2, Vav, Cbl, talin, paxillin, and vinculin, along
with the activation of PI3K, have been described as mediators of
actin cytoskeleton reorganization (Suen et al., 1999; Caveggion
et al., 2003; Chodniewicz and Zhelev, 2003; Tybulewicz et al.,
2003; Nayal et al., 2004; Mitra et al., 2005). These events
promote cell spreading, adhesion, and motility, resulting in
monocyte recruitment to areas of infection. When cells were
stained for F-actin fibers, we found that CpG treatment induced
strong actin polymerization in both mouse macrophages and
human monocytes (Fig. 2). These rearrangements translated to
rapid cell spreading, conspicuous morphological changes, and
increased cell size. In the case of THP-1 cells, CpG treatment
[ID]FG2/
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induced the formation of actin-rich lamellipodia structures.
Similar to CpG-induced tyrosine kinase phosphorylation (Fig. 1),
the TLR9 inhibitor chloroquine was unable to block CpGinduced actin reorganization (Fig. 2).
CpG induces the transient adhesion
of monocytes

SFK-initiated actin reorganization can also facilitate cell
adhesion to promote the recruitment of cells to tissues infected
by pathogens. Because CpG induced cytoskeleton reorganization, we next tested the ability of CpG to induce monocyte
adhesion. When human monocytes were stimulated with CpG,
they rapidly adhered in culture, with maximal adhesion detected at 30 min (Fig. 3, A and C). A negative control GpC-ODN
failed to induce monocyte adhesion. Interestingly, a timecourse analysis of CpG-induced adhesion indicated that this
event was transient, with cells detaching after 2 h (Fig. 3, A
and C). Overnight culture of CpG-stimulated monocytes
revealed that cells eventually reattach, an event that we hypothesize is driven by secondary CpG-induced effects, such as
[ID]FG3/
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Figure 3. CpG-induced cell adhesion is insensitive to chloroquine but requires SFK activity.
(A) Cells were stimulated with 1 μg/ml of a
control GpC-ODN or with CpG–ODN 2216
for the indicated times (min). After ﬁxation,
cells were visualized as described in Materials
and methods. (B) THP-1 cells were preincubated for 10 min with chloroquine, quinacrine,
PP2, and PP3. The number at the lower right
corner of each panel indicates the concentration for each inhibitor used (μM). Cells were
then stimulated for 30 min with CpG, and adhesion was measured. Representative ﬁelds
are presented. (C) THP-1 cells were stimulated
as indicated in A, and images captured from
36 different ﬁelds from at least four different
wells were quantiﬁed to obtain cell number per
ﬁeld and plotted with the SD. (D) THP-1 cells
were stimulated for 20 min with increasing
concentrations of CpG, control GpC, the B
class oligo 2006 (ODN 2006), and murine
CpG (mCpG), and adhesion was measured.
(E) Adhesion was measured on THP-1 cells that
were pretreated for 10 min with increasing
concentrations of PP2, PP3, and herbimycin A
and then stimulated with CpG for 30 min.
Data are represented as percentage of adhered cells versus vehicle-pretreated cells.
(F) THP-1 cells were preincubated for 10 min
with increasing concentrations of chloroquine
or quinacrine. Cells were then stimulated for
30 min with CpG, and the number of adhered
cells from at least 36 different ﬁelds was quantiﬁed. Error bars indicate SD.

Published March 27, 2006

SFK-dependent cellular responses
are chloroquine insensitive

Chloroquine blocks CpG interaction with TLR9 at the endosome (Rutz et al., 2004), and our previous findings indicated
that although CpG-induced tyrosine kinase activation was
blocked by the SFK inhibitor PP2, it was insensitive to chloroquine (Fig. 1 C). We therefore tested the ability of chloroquine
and quinacrine to modulate CpG-induced adhesion. Even at
high concentrations that completely inhibit TLR9-induced
cytokine production (10 μM for chloroquine and 1 μM for
quinacrine), both inhibitors failed to block CpG-induced adhesion
(Fig. 3, B and F).

Figure 4. CpG-induced chloroquine-insensitive adhesion of human DCs.
(A) Adhesion was measured in human monocyte–derived immature DCs,
as described in Fig. 3. Cells were stimulated with CpG–ODN 2216, and
the number of adhered cells was obtained at the indicated times. White
bars represent background adhesion, gray bars indicate adhesion in the
presence of a control GpC-ODN, and black bars indicate adhesion induced by CpG-ODN. Error bars indicate SD. (B) DCs were preincubated
for 15 min with chloroquine (CQ; 10 μM), quinacrine (Qu; 1 μM), herbimycin A (5 μM), PP2 (1 μM), and PP3 (1 μM). Cells were then stimulated
with GpC and CpG-ODN, and adhesion was quantiﬁed as previously
described. (C) pDCs puriﬁed from human PBMCs were incubated with the
indicated concentrations of chloroquine and quinacrine in the presence
of CpG for 18 h. Culture supernatants were analyzed for secreted IFN-α
by ELISA.

Downloaded from jcb.rupress.org on November 8, 2011

chemokine secretion, because it can be blocked by chloroquine
(unpublished data).
Next, we further characterized the ability of different
CpG-ODNs to induce adhesion. We found that the human CpGODN that induced robust tyrosine phosphorylation also induced
adhesion in a concentration-dependent manner (Fig. 3 D).
Although 2 μg/ml CpG produced the highest level of adhesion,
0.5 μg/ml was sufficient to induce significant adhesion (Fig. 3 D).
A GpC control ODN or a mouse-selective CpG-ODN was
unable to induce significant cell adhesion at any concentration
tested. Interestingly, when we compared the performance of
an A class ODN with that of a B class ODN (ODN 2006), we
found that the latter yielded a less pronounced adhesion response (Fig. 3 D). This also correlated with a poor induction
of the tyrosine phosphorylation cascade (unpublished data).
Although only immunostimulatory CpG promotes cytoskeleton
rearrangement, it has been reported that both immunostimulatory and nonimmunostimulatory ODNs are internalized at the
same rate in a time-, dose-, and temperature-dependent manner
(Hacker et al., 1998; Guo and Schluesener, 2004; Takeda and
Akira, 2005; unpublished data), indicating that CpG-induced
SFK activation does not enhance ODN uptake. This is consistent with our observations that PP2 treatment had no effect on
CpG internalization (unpublished data).
Our previous experiments indicated that inhibition of SFKs
blocked the phosphorylation of proteins that promote cellular
adhesion, such as Pyk2 and Vav1 (Fig. 1). Based on these data, we
hypothesized that the SFK inhibitor PP2 would also block monocyte adhesion. When we tested this hypothesis, we found that
PP2 potently blocked CpG-induced adhesion, even at concentrations below the micromolar range (Fig. 3, B and E). As expected,
the control inhibitor PP3 had no effect on monocyte adhesion.
Herbimycin A, another SFK inhibitor, also blocked monocyte
adhesion at submicromolar concentrations (Fig. 3 E). Actin-driven
morphological changes are dynamic processes mediated by the
polymerization and depolymerization of actin fibers. Therefore,
we examined the effects of the actin microfilament–disrupting
drugs cytochalasin D, latrunculin A, and jasplakinolide. All three
inhibitors potently blocked monocyte adhesion at the nanomolar
range (Fig. S1, available at http://www.jcb.org/cgi/content/full/
jcb.200508058/DC1). Together, these data indicated that CpGtriggered SFK activation initiates a tyrosine-kinase signaling
cascade in monocytes that results in actin-driven cytoskeleton
changes that promote cell adhesion.

To corroborate our findings using primary cells, we
repeated these studies using immature human DCs. Similar
to a human monocytic cell line, CpG induced adhesion of
human monocyte–derived DCs, whereas GpC did not (Fig.
4 A). In immature DCs, we found that SFK inhibitors are
able to effectively block CpG-induced adhesion (Fig. 4 B).
Although chloroquine and quinacrine blocked IFN-α secretion from peripheral blood mononuclear cells (PBMCs) at
concentrations of <10 and 1 μM, respectively (Fig. 4 C),
they were unable to block CpG-induced adhesion at similar
concentrations (Fig. 4 B).
[ID]FG4/
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Another prominent cytoskeleton-dependent process is cell
motility. All of the identified CpG-induced phosphoproteins
have been implicated in driving or regulating cell motility
(Fig. 1 B). As previously described (Baek et al., 2001), we found
that monocytes migrate toward a CpG gradient (Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb. 200508058/DC1).
As in the case of adhesion, chloroquine and quinacrine failed
to block monocyte migration in response to CpG (Fig. S2).
CpG-triggered SFK activation is required
for cytokine secretion

The secretion of CpG-induced inflammatory cytokines is dependent on NF-κB translocation to the nucleus (Krieg, 2002b).
The negative regulator of NF-κB activation, IκB-α, is phosphorylated and degraded after 5 min and remains strongly phosphorylated 45 min after CpG treatment (Fig. 5 A). As expected,
the TLR9 inhibitor chloroquine blocked IκB-α phosphorylation
and degradation in monocytes (Fig. 5 A). Our previous results
(Fig. 1) indicated that CpG-induced SFK activation precedes
IκB-α phosphorylation and degradation, which are undetectable at 2.5 min as compared with maximal CpG-induced tyrosine phosphorylation at 3 min after CpG treatment. Given the
rapid kinetics of SFK activation and insensitivity to chloroquine
treatment, we hypothesized that CpG-induced tyrosine phosphorylation is upstream of IκB-α phosphorylation. When we
tested this hypothesis in macrophages, we found that the SFK
inhibitor PP2 effectively blocked IκB-α phosphorylation upon
CpG stimulation (Fig. 5 B). Like chloroquine, the SFK inhibitor
[ID]FG5/

1062

JCB • VOLUME 172 • NUMBER 7 • 2006

PP2 also inhibited CpG-induced IFN-α secretion in immature
human plasmacytoid DCs (pDCs; Fig. 5 C). Furthermore, PP2
effectively blocked CpG-induced IL-6 secretion (Fig. 5 D) and
the up-regulation of B cell activation markers such as CD40 and
CD69 (Fig. 5 E). To complement our pharmacological inhibitor
data, we established a small interfering RNA (siRNA) system to
specifically knock down the expression of Lyn and Hck, two
leukocyte SFKs that we identified as being activated by CpG.
Immunoblot analysis of siRNA-transfected cell lysates revealed
that an 80% knockdown of Lyn and a >90% knockdown of Hck
was achieved (Fig. 6 A). When these cells were used in a CpGinduced adhesion assay, single knockdown of Lyn or Hck resulted in a significant decrease in cellular adhesion (Fig. 6 B).
A combined knockdown of Lyn and Hck further decreased
CpG-induced adhesion by 60%. The residual adhesion is most
probably mediated by other SFKs, such as Blk, Fyn, and Src.
Moreover, analysis of cytokine production revealed a similar
trend, where combined knockdown of Lyn and Hck reduced
CpG-induced TNFα production by 60% (Fig. 6 C). Together,
both the pharmacological inhibitor and genetic data indicated
that early activation of SFKs plays a key role in CpG-induced
activation of monocytes.
[ID]FG6/

CpG-triggered SFK activation
is upstream of MyD88 and originates
at the plasma membrane

The SFK pathway remains intact even when the TLR9– MyD88
signaling pathway is blocked using chloroquine. Next, we used
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Figure 5. CpG-induced SFK activation is upstream of NF-𝛋B activation. (A) Raw cells lysates were collected after CpG treatment (ODN 1585) in the
presence or absence of 10 μM chloroquine (CQ). IκB-α was immunoprecipitated, and the product was resolved by SDS-PAGE and immunoblotted with a
phospho–IκB-α antibody. The degradation of IκB-α was also detected using an IκB-α antibody. (B) Cells were pretreated with the SFK inhibitor PP2 and its
control PP3. Lysates were analyzed as described in A. (C) Isolated pDCs from human blood were cultured for 18 h and then preincubated for 15 min with
vehicle or PP2 (2 μM). Cells were then stimulated with 5 μM CpG. After 24 h of culture, supernatants were taken and analyzed for type I interferon levels.
(D) Splenocytes from B6 mice were pretreated for 1 h with increasing concentrations of PP2, PP3, and chloroquine and then stimulated with CpG for
12 h. Supernatants were analyzed for IL-6 secretion by ELISA. Error bars indicate SD. (E) Splenocytes from D were analyzed for CpG-induced up-regulation
of CD69 and CD40 by FACS. Unshaded versus shaded histogram for each panel represents the following: untreated versus CpG stimulated (top), and
untreated versus CpG plus chloroquine treatment (middle). (bottom) B cells pretreated with PP2 (unshaded) versus PP3 (shaded) after CpG treatment.
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Figure 6. Knockdown of SFK expression by siRNA signiﬁcantly inhibits
CpG-induced adhesion and cytokine production. (A) THP-1 cells were
transfected with control-scrambled siRNA or siRNA pools for Lyn, Hck,
or both kinases and then cultured for 48 h. Gene knockdown was visualized by immunoblotting lysates with anti-Lyn or anti-Hck antibodies.
(B) Cells from A were stimulated with GpC control or CpG–ODN 2216
(1 μM) for 20 min and tested in an adhesion assay, as described in
Fig. 3 A. (C) THP-1 cells from A were plated at 5 × 105 cells/well in
triplicate. Cells were stimulated with a GpC control or CpG–ODN 2216
for 4 h. TNFα in culture supernatants was measured by ELISA. Error bars
indicate SD.

an alternative method to pharmacological inhibitors to confirm
our results. Because the adaptor protein MyD88 is required for
signal transduction downstream of TLR9, we decided to test
whether the CpG-induced tyrosine phosphorylation cascade is
intact in the absence of MyD88. The same intensity and kinetics
of phosphorylation was observed in both control and MyD88−/−
macrophages stimulated with CpG-ODN (Fig. 7 A). Consistent
with our previous results, chloroquine treatment did not block
CpG-induced tyrosine phosphorylation in either wild-type or
MyD88−/− macrophages (Fig. 7 A). Although the SFK pathway
was intact in MyD88−/− macrophages, CpG treatment was unable to induce translocation of the p65 subunit of NF-κB to the
nucleus (Fig. 7 B). Consequently, NF-κB–driven responses such
as the up-regulation of CD40 and CD69 and the secretion of IL-6
[ID]FG7/

Figure 7. CpG activates SFKs at the plasma membrane and upstream of
the MyD88 activation. (A) Thioglycollate-elicited peritoneal macrophages
were obtained from wild-type and MyD88−/− mice and cultured for 24 h
in medium containing 0.5% FBS. Cells were pretreated with 10 μM chloroquine (CQ) or vehicle for 15 min and stimulated with CpG–ODN 1585
for 5 min. Tyrosine phosphorylation after CpG treatment was visualized by
immunoblotting with an anti-pTyr antibody. (B) Murine bone marrow–
derived DCs from wild-type and MyD88−/− mice were pretreated with
10 μM chloroquine or vehicle for 15 min, and after CpG stimulation, cells
were stained with an antibody to the p65 subunit of NF-κB. (C) CpG- or
GpC-coated 10-μm red ﬂuorescent polystyrene beads were added to RAW
cells for 20 min. Cells were then ﬁxed and stained with FITC-phalloidin.
The yellow arrow indicates the location of cells.

were impaired in cells from MyD88−/− mice (Fig. S3, available
at http://www.jcb.org/cgi/content/full/jcb.200508058/DC1).
Because our data indicated that the SFK pathway was
activated at the cell surface, we decided to directly test this

A NEW CPG-INDUCED TLR9-INDEPENDENT PATHWAY • SANJUAN ET AL.

1063

Published March 27, 2006

hypothesis by stimulating cells with CpG-ODN that are
unable to be internalized. 10-μm red fluorescent polystyrene
beads that are large enough to avoid internalization by macrophages were coated with CpG or control GpC-ODN. Upon
incubating these beads with mouse macrophages for 20 min,
we observed strong actin polymerization localized specifically
at the plasma membrane of the cell–bead contact area (Fig. 7 C).
Beads coated with CpG, but not with the control GpC-ODN,
specifically induced this actin polymerization. Consistent with
our previous findings, actin reorganization was chloroquine
insensitive (Fig. 7 C).
The SFK pathway is TLR9 independent
but intersects with the MyD88 pathway

It has recently been reported that CpG-induced Akt phosphorylation occurs via a TLR9-independent pathway (Dragoi et al.,
2005). It is possible that the chloroquine-insensitive SFK pathway
that we describe originates at the plasma membrane in a TLR9independent manner, similar to that described for Akt phosphorylation. Once CpG is internalized into endosomes, it would interact
with TLR9 and initiate the chloroquine-sensitive TLR9–MyD88
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pathway. To test this hypothesis, we stimulated TLR9−/− macrophages with CpG and obtained a pattern of tyrosine phosphorylated proteins similar to that of wild-type macrophages, indicating
that CpG-induced SFK activation is intact in cells lacking TLR9
(Fig. 8 A). Furthermore, the downstream actin cytoskeleton rearrangements were also unperturbed in cells from both TLR9−/−
and MyD88−/− mice stimulated with CpG-coated beads (Fig. 8 B).
These data indicate that this pathway is both TLR9 independent
and initiated at the cell surface before CpG endocytosis. Although
CpG recognition can happen before CpG internalization, as we
show here, it has been demonstrated that CpG internalization is
required for cell activation and cytokine production (Krieg et al.,
1995; Manzel and Macfarlane, 1999; Ahmad-Nejad et al., 2002).
In accordance with these findings, plate-bound CpG was unable
to induce IL-6 secretion (Fig. 8 C). Although the TLR9–MyD88
pathway was impaired when CpG was immobilized, confocal
analyses indicated that CpG-induced cytoskeletal rearrangements
were intact (Fig. 8 D). Macrophages stimulated with CpG immobilized on plastic generated large, actin-rich lamellipodia. Similar
actin rearrangements were observed in macrophages from
MyD88−/− and TLR9−/− mice (Fig. 8 D).
[ID]FG8/
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Figure 8. CpG-induced SFK activation is a
TLR9-independent event. (A) Thioglycollateelicited peritoneal macrophages were obtained
from wild-type (WT) and TLR9−/− mice. After
24 h of culture in medium (0.5% FCS), cells were
stimulated with CpG–ODN 1585 for 5 and
10 min.Tyrosine phosphorylation after CpG treatment was visualized by immunoblotting with an
anti-pTyr antibody. (B) Peritoneal macrophages
obtained from wild-type, MyD88−/−, and
TLR9−/− mice were cultured for 24 h, and CpGor GpC-coated 15-μm red ﬂuorescent polystyrene beads were added for 20 min. Cells were
then ﬁxed and stained with FITC-phalloidin.
(C) High-binding 96-well plates were coated with
100 μl of a CpG solution for 15 h at 0.5 and
1 μg/ml, and unbounded ODN were removed
by washing thoroughly. Peritoneal macrophages were plated at 2 × 105 cells per well.
A different group of cells was stimulated with
soluble CpG at the indicated concentration.
15 h later, supernatants were collected and secreted IL-6 was measured by ELISA. (D) Freshly
isolated peritoneal macrophages were allowed
to attach for only 10 min to wells previously
covered with CpG and GpC. After paraformaldehyde ﬁxation, cells were stained with FITCphalloidin (green) and nuclei were visualized
with TOPRO-3 (red). (E) Adhesion was assayed
in THP-1 cells pretreated with wortmannin
at increasing concentrations, as previously
described. (F) THP-1 cells were pretreated with
10 μM chloroquine (CQ), 1 μM PP2, and
1 μM wortmannin (W) for 20 min. After CpG
stimulation for 5 min, the phosphorylation of
Akt was analyzed by Western blot. (G) THP-1
cells expressing Flag-TLR9 were pretreated with
10 μM chloroquine and 1 μM PP2 for 20 min.
After stimulating the cells for 5 min, samples
were lysed and TLR9 was immunoprecipitated
using an anti-Flag antibody. Flag-TLR9 and Syk
were then detected by Western blot. (H) Cells
were pretreated as before and also with Syk
inhibitor (SI). Immunoprecipitated TLR9 was
assayed with anti-pTyr (4G10).
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Discussion
CpG-containing ODNs activate TLR9 in endosomes and trigger
the secretion of inflammatory cytokines by a mechanism that is
dependent on the adaptor protein MyD88 (Krieg, 2002b; Takeda
et al., 2003). We demonstrate that cellular activation by immunostimulatory ODNs is more complex than previously described
and requires a TLR9-independent SFK-driven pathway. This
SFK-dependent signaling cascade is not parallel but upstream
of the chloroquine-sensitive TLR9–MyD88 pathway.
We first provide evidence that stimulation with CpG, but
not the control GpC, induces a complex pattern of tyrosine
phosphorylation in monocytes. While characterizing several
of these phosphorylated proteins, we identified two SFKs expressed in myeloid cells, Hck and Lyn. Treatment of monocytes
with the SFK inhibitor PP2 inhibited the CpG-induced tyrosine
phosphorylation cascade. Interestingly, treatment with chloroquine and quinacrine, two known inhibitors of TLR9 signaling,
failed to block tyrosine phosphorylation.
In addition to the kinases Hck and Lyn, we found that
CpG also induced the phosphorylation of Pyk2, Cbl, and the
previously described CpG-activated Vav (Stovall et al., 2004).
These proteins are required for adhesion and migration responses that involve rearrangement of the actin cytoskeleton

(Suzuki et al., 2000; Latour and Veillette, 2001). For example,
the phosphorylation of Pyk2 by SFKs, along with the participation of other focal adhesion proteins, promotes actin cytoskeleton rearrangements that induce cell adhesion, spreading, and
lamellipodia formation (Suen et al., 1999). Cbl, which interacts
with Pyk2, Vav, and SFKs, has been associated with increased
motility of macrophages (Caveggion et al., 2003). Vav, a multidomain signal integrator, transduces signals to cytoskeletondependent pathways, which include the PI3K pathway and the
activation of extracellular signal–regulated kinase and NF-κB
(Tybulewicz et al., 2003). The phosphorylation of Pyk2, Cbl,
and Vav upon CpG stimulation suggested that actin reorganization plays an important role upon CpG stimulation. Indeed,
our experiments confirmed that CpG triggered the reorganization of the actin cytoskeleton, promoting cell adhesion and
migration. We found that CpG treatment induced a transient,
SFK-dependent cell adhesion in human monocytes but not when
cells were stimulated with either control GpC-ODN or a mouseselective CpG-ODN. Again, the TLR9 inhibitor chloroquine
was unable to block CpG-induced adhesion and migration of
THP-1 monocytes and adhesion on human monocyte–derived
DCs; however, those cellular responses were completely
blocked with an SFK inhibitor.
CpG-induced SFK signaling was upstream and required
for NF-κB activation and subsequent cytokine secretion. SFK
inhibitors blocked CpG-induced secretion of IL-6 in splenocytes, IFN-α production in human pDCs, and the up-regulation
of activation markers on murine B cells. Furthermore, we found
that SFK activation was intact in MyD88−/− mice, indicating
that this pathway is both upstream and independent of MyD88.
The rapid kinetics of tyrosine phosphorylation suggested
that this event was initiated at the cell surface and independent
of the endosomal localized TLR9. The use of CpG-coated
beads, too large to be internalized, revealed that CpG induced
robust, rapid actin reorganization at the bead–cell contact area,
further suggesting that these events did not require internalization of CpG. The use of TLR9−/− and MyD88−/− monocytes indicated that these cellular events were independent of TLR9 and
MyD88 in addition to being chloroquine insensitive. Together,
these studies indicated that CpG-induced SFK activation at the
plasma membrane drives cytoskeletal reorganization upstream
and independently of the TLR9–MyD88 pathway that could result in cell adhesion and migration. In support of our findings, it
was recently reported that, upon DNA viral infection of mice,
leukocyte recruitment to the liver is not altered in TLR9−/− and
MyD88 −/− mice, whereas the secretion of cytokines in vivo
was dramatically reduced (Delale et al., 2005).
Our findings indicate that the recognition of CpG-ODN
is more complex than previously described, but as reported
(Krieg et al., 1995; Manzel and Macfarlane, 1999), this
TLR9-independent pathway cannot induce cytokine secretion
without ODN internalization. Although plate-bound CpG
induced the formation of large lamellipodia in macrophages
from wild-type, TLR9−/−, and MyD88−/− mice, it was unable
to induce IL-6 secretion.
The TLR9 receptor responds differently to the three identified ODN classes (A, B, and C). The mechanism by which
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Next, we examined whether the CpG-induced SFK pathway is upstream of the previously described TLR9-independent
phosphorylation of Akt (Dragoi et al., 2005). Activation of
SFKs promotes actin reorganization through the participation of
PI3K, an upstream regulator of Akt (Franke et al., 1997). Treatment of cells with the PI3K inhibitor wortmannin inhibited both
CpG-induced cell adhesion (Fig. 8 E) and phosphorylation of
Akt (Fig. 8 F). Furthermore, use of the SFK inhibitor PP2
blocked CpG-induced Akt phosphorylation (Fig. 8 F), indicating that the SFK pathway is upstream of the previously reported
TLR9-independent phosphorylation of Akt.
Given that the CpG-induced SFK pathway originates at the
plasma membrane and TLR9 is itself located in endosomes, we
next wanted to investigate how these two pathways intersect.
Recently, Syk, a CpG-activated kinase that we identified (Fig. 1),
was reported to be a key component in the innate response to
zymosan (Rogers et al., 2005). Syk was shown to couple to the
β-glucan receptor Dectin-1 and work synergistically with TLR2
to mount an immune response to zymosan. Using a THP-1 cell
line expressing a Flag-tagged TLR9, we found that upon CpG
stimulation Syk coimmunoprecipitates with TLR9 (Fig. 8 G).
This interaction provides a link between the SFK pathway and
the MyD88 pathway. This interaction is unperturbed in the presence of the TLR9 inhibitor chloroquine, suggesting that it occurs
before the generation of a signal through TLR9. Both the SFK inhibitor PP2 and a specific Syk inhibitor blocked the interaction
of Syk with TLR9. To further examine the association of Syk
with TLR9, we examined whether TLR9 itself was tyrosine
phosphorylated. CpG treatment did indeed induce tyrosine phosphorylation of TLR9 (Fig. 8 H). Consistent with our previous experiments, this event was chloroquine insensitive but completely
blocked by PP2 and partially blocked with a Syk inhibitor.
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these diversified responses are generated remains unresolved
(Vollmer et al., 2004). It has been hypothesized that TLR9 requires additional coreceptors/cofactors, as is the case for TLR4
(Verthelyi and Zeuner, 2003), for the recognition of CpG–A
class ODNs (Gursel et al., 2002). Our findings support this hypothesis because SFK activation and downstream cellular events
are most strongly triggered by CpG–A class ODN when compared with B class ODN. Based on our preliminary characterization of this pathway, we hypothesize that a CpG-sensing
coreceptor/cofactor is localized at the plasma membrane, which
could also potentially be internalized with CpG-ODN, resulting
in endosomal TLR9 activation (Fig. 9). Until this pathway is
further characterized, it remains possible that this coreceptor/
cofactor is also localized in the endosome in resting cells.
The role of PI3K family on TLR signaling is poorly
understood. PI3K interacts with the cytosolic Toll/IL-1 receptor
domain of TLR2 (Arbibe et al., 2000) and has been found activated downstream of IRAK1 in response to IL-1β (Neumann
et al., 2002). Recently, Akt, a downstream effector of the SFK–
PI3K pathway (Franke et al., 1997), was shown to be phosphorylated in response to CpG by a TLR9-independent mechanism
that involves DNA-dependent protein kinase (Dragoi et al.,
2005). In our experimental system, Akt phosphorylation was
intact in chloroquine-treated cells, indicating that the MyD88
cascade is not involved in Akt activation. However, Akt phosphorylation was completely blocked by both PP2 and the PI3K
inhibitor wortmannin. These data indicate that the TLR9[ID]FG9/
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Materials and methods
Cells
THP-1 and RAW264.7 (RAW) cells were obtained from American Type
Culture Collection and cultured in RPMI 1640 medium (Invitrogen) supplemented with 10% FCS (Invitrogen), 2 mM L-glutamine, and antibiotics.
Flag-TLR9 stable transfected THP-1 were selected after transfecting THP-1
with NH2-terminal–tagged version of hTLR9 cloned in p3× Flag-CMV-9,
where original TLR9 leader peptide was replaced by the one provided in
the vector. TLR9−/− and MyD88−/− mice were provided by S. Akira (Osaka
University, Suita, Japan). Single-cell spleen suspensions from wild-type
(C57BL/6 background) and MyD88−/− mice were obtained after mincing
spleens and lysing erythrocytes. Cells were then cultured in RPMI 1640
medium supplemented with 10% FCS. Human monocyte–derived DCs were
derived from human peripheral blood as previously described (Vincent
et al., 2002). Human pDCs were isolated from PBMC using the BDCA-4
isolation kit (Miltenyi Biotec). Puriﬁed pDCs were cultured for 16–20 h
in RPMI 1640 supplemented with 10% FCS, GlutaMAX, kanamycin, and
Na-pyruvate (all from Invitrogen). IL-3 (R&D Systems) was added to a ﬁnal
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Figure 9. A model for the two-step activation by CpG-DNA. We propose
that the recognition of A class CpG-DNA is a two-step process that can
begin at the plasma membrane (PM) by a TLR9-independent mechanism.
We hypothesize the existence of a receptor, localized at the plasma
membrane, which is able to distinguish CpG- versus GpC-DNA. CpG-DNA
stimulation of this receptor would activate two SFKs, Hck and Lyn, that
would initiate a tyrosine phosphorylation cascade that can be fully inhibited with the inhibitor PP2. SFK-mediated actin ﬁlament rearrangement is
upstream of cell adhesion, spreading, and migration. One downstream
effector of the SFK pathway, Syk, interacts with TLR9. The second CpGinduced activation event occurs at the endosome when internalized
CpG-DNA binds TLR9 and initiates the MyD88-dependent cascade that is
chloroquine sensitive.

independent tyrosine phosphorylation cascade that we describe
is upstream of Akt activation.
Finally, we provide evidence that the SFK pathway does
intersect with the TLR9–MyD88 pathway. TLR9 is tyrosine
phosphorylated upon CpG stimulation, and this event is independent of chloroquine but blocked by PP2. Furthermore, Syk
coimmunoprecipitates with TLR9 upon CpG stimulation, and
this interaction can be blocked by PP2. Because Syk is normally
recruited to ITAM-containing receptors, which is not the case of
TLR9, it is likely that the TLR9–Syk association is indirect and
that other proteins participate in the formation of a complex.
Two potential ITAM chains, the γ chain of the Fc receptor and
DAP12 (DNAX-activating protein of 12 kD) were examined,
but no phosphorylation was detected upon CpG stimulation
(unpublished data). Although our experiments do not reveal
whether Syk associates directly with TLR9, coimmunoprecipitation after CpG stimulation is not affected by chloroquine, indicating that this event is driven by the initial SFK pathway
independently of TLR9. This link between tyrosine kinase signaling and TLRs is further supported by a recent study involving TLR3, a receptor for double-stranded RNA. Like TLR9,
TLR3 is tyrosine phosphorylated, and this event is linked to
PI3K-mediated enhancement of the interferon regulatory factor 3
pathway (Sarkar et al., 2004). Unlike our findings with TLR9,
TLR3 phosphorylation does not regulate NF-κB activation.
In conclusion, we describe a TLR9-independent, SFKdriven signaling cascade induced by CpG. This cascade is
upstream of the MyD88-dependent endosomal pathway and is
initiated at the plasma membrane. This chloroquine-insensitive
pathway initiates complex cytoskeletal rearrangements necessary for cell biological events such as adhesion and migration.
Moreover, these two pathways interact, as inhibition of the SFK
pathway blocks activation events downstream of endosomal
TLR9/MyD88 such as NF-κB activation and cytokine secretion.
Our findings suggest that a potential CpG-sensing receptor is
localized at the plasma membrane and might interact with CpG
before the activation of endosomal TLR9. Future studies are required to identify candidate proteins that would perform this
function. The identification of a TLR9 coreceptor would potentially provide a new target for pharmaceutical intervention that
could result in new treatments for autoimmune diseases.
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concentration of 20 ng/ml. Unless indicated in the ﬁgure legends, type I
interferon levels in culture supernatants were measured by evaluating the
inhibition of Daudi cell proliferation with reference to a standard IFN-α
curve (Nederman et al., 1990).
Murine B cells were obtained by negative selection, removing attached cells and then using anti-Thy1.2 magnetic beads (Dynal). Murine
bone marrow–derived DCs were generated from bone marrow progenitors
as described by Lutz et al. (1999). In brief, freshly prepared bone marrow
cells were cultured in RPMI 1640 medium supplemented with 10% heatinactivated FCS, 2 mM L-glutamine, 10 mM Hepes buffer, 50 μg/ml penicillin, and nonessential amino acids in the presence of 200 U/ml GM-CSF
(granulocyte-macrophage colony-stimulating factor; Sigma-Aldrich).
Cultures were supplemented with GM-CSF on days 3 and 8. Murine-elicited
macrophages were obtained by peritoneal lavage 4 d after peritoneal injection of 2 ml of thioglycollate broth (Sigma-Aldrich). They were washed
three times in FCS-supplemented serum and then plated. 1 h later, unattached cells were discarded. For biochemistry, cells were cultured for 24 h
in DME supplemented with 0.5% FCS, 2 mM L-glutamine, 50 ng/ml IFN-γ,
and antibiotics and then stimulated as indicated in ﬁgure legends.

Cell transfection
Human Hck and Lyn siRNA SMARTpools were obtained from Dharmacon.
THP-1 cells were transfected with 100 nM of each siRNA or in combination
using a Nucleofector and Kit V according to the manufacturer’s recommendations (Amaxa Biosystems). Cells were cultured for 48 h and then analyzed in adhesion and cytokine assays.
Cell lysis and immunoblotting
Cells were lysed in RIPA buffer for 30 min on ice (50 mM Tris, pH 7.5,
150 mM NaCl, 1% Triton X-100, 0.5% DOC, 0.1% SDS, protease inhibitor
tablet [Roche], 1 mM NaF, 1 mM Na3VO4, and 1 mM PMSF). After centrifugation (20,000 g, 10 min, 4°C), supernatants were analyzed by SDSPAGE. For anti-paxillin, anti-talin, and anti-vinculin immunoprecipitations,
cells were lysed directly in sample buffer containing 1% SDS, boiled, and
diluted 10-fold with 1% Triton X-100 containing lysis buffer.
Immunoﬂuorescence
Cells were stimulated as indicated in ﬁgure legends and then ﬁxed with
4% paraformaldehyde in PBS, washed twice with PBS, and blocked with 2%
BSA in PBS for 2 h. All incubations and washes were performed in 0.5%
BSA and 0.1% Triton X-100 in PBS. Antibody staining was performed at
37°C in a moist chamber for 1 h. F-actin was stained with FITC-phalloidin
for 20 min, cells were washed twice in PBS, and nuclei were stained with
TOPRO-3 for 20 min. Samples were mounted, and images were captured
with a confocal microscope (IX70; Olympus) using the uPlanApo 100×/1.35
lens and Fluoview 2.0 (Olympus) program. For immobilized ODN microsphere cell binding, 106 microsphere beads were coated with a 1-mg/ml
solution of GpC or CpG-ODN overnight and then washed four times in
culture medium. Coated microspheres (10-μm diameter for RAW cells or
15 μm for peritoneal macrophages) were added to cells in culture at a
microsphere/cell ratio of 3:1. Cells were ﬁxed after an incubation of 20 min.

ELISA
Single-cell splenocyte suspensions or human pDCs (5 × 105 cells/well)
were stimulated for 24 h with 1 μM ODN. Supernatants were collected,
and IL-6 or IFN-α (R&D system) were measured by ELISA according to the
manufacturer’s instructions.
Flow cytometry
Splenocytes were stained and analyzed on a FACScalibur (Becton
Dickinson). For measuring up-regulation of B cell activation markers, cell
surface expression of CD40 and CD69 were analyzed on gated B-220–
positive cells. The cells were stained with FITC-conjugated anti-CD40, antiCD69, and allophycocyanin-conjugated anti-B220 from BD Biosciences.
Online supplemental material
Fig. S1 shows the effect of the microﬁlament-disrupting drugs cytochalasin D,
latrunculin A, and jasplakinolide on CpG-induced adhesion. Fig. S2 shows
that chloroquine and quinacrine are unable to block CpG-induced cell
motility. Fig. S3 shows that MyD88−/− mice are unresponsive to CpG as
measured as the secretion of IL-6 or the up-regulation of the plasma membrane level of CD40 and CD69. Online supplemental material is available
at http://www.jcb.org/cgi/content/full/jcb.200508058/DC1.
The authors wish to thank Dr. Douglas R. Green at St. Jude Children’s Research
Hospital for his support during the last months of manuscript preparation.
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